Direct and indirect costs among employees with diabetic retinopathy in the United States

Authors:

Abstract
Objective: To examine, from the employer perspective, the direct (healthcare) and indirect (workloss) costs of employees with diabetic retinopathy (DR) compared to control non-DR employees with diabetes, and within DR subgroups.Methods: Compared annual costs using claims data from 17 large companies (1999–2004). ‘DR employees’ (n = 2098) had ≥ 1 DR (International Classification of Disease, 9th Revision [ICD‑9]) diagnosis; DR subgroups included employees with diabetic macular edema (DME), proliferative DR (PDR), and employees receiving photo­coagulation or vitrectomy procedures. Descriptive and multivariate tests were performed.Results: DR employee annual direct costs were $18 218 (indirect = $3548) compared to $11 898 (indirect = $2374) for controls (Δ = $2032 (adjusted); p < 0.0001). Costs differences were larger across DR employee subgroups: DME/non-DME ($28 606/$16 363); PDR/non-PDR ($30 135/$13 445; p < 0.0001); DR with/without photocoagulation ($34 539/$16 041; p < 0.0001); and DR with/withou...

This publication has 21 references indexed in Scilit: